Yes, it is curious how money finds a way of getting to certain points in the U.S.healthcare structure. Why A2-73 remains in the shadows is a puzzle to some degree. Funding from NIH suggests credibility for the study even though they should know a study of (possibly) permanent AD treatment is not funded. What are we missing here?